Aptose Announces Receipt of Deficiency Notice from Nasdaq
SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: ...
Read more
ADVERTISEMENT
ADVERTISEMENT
Tag: aptose
Aptose Announces Results from Annual and Special Meeting of
SAN DIEGO and TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: ...
Read moreAptose Presents Tuspetinib (TUS) Clinical and Preclinical
TUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) ...
Read moreAptose Announces Closing of $4.43 Million Registered Direct
SAN DIEGO and TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: ...
Read moreAptose Announces $4.43 Million Registered Direct Offering
SAN DIEGO and TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: ...
Read moreAptose Announces Pricing of $8.4 Million Public Offering
SAN DIEGO and TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (Nasdaq: APTO, TSX: ...
Read moreAptose Tuspetinib Clinical Data Featured in Oral
Reporting Complete Response Data from the Ongoing APTIVATE International Phase 1/2 Study of Tuspetinib (TUS) in Relapsed/Refractory AML PatientsTUS Single ...
Read more
LifeCare News is a registered magazine in RNI (Registrar of Newspapers for India) is started in 2015, as well as Lifecarenews have a malti language portal. Life Care News portal was connected with many reputed news agency.